New rheumatoid arthritis drug candidate begins first human tests
Disease control
Recruiting now
This early-stage study is testing a new drug called CIGB-814 for safety and how the body processes it. 70 healthy volunteers aged 18-45 will receive either the drug or a placebo as a single or multiple injections. The goal is to see if it is safe enough to test in people with rhe…
Phase: PHASE1 • Sponsor: Yi Fang • Aim: Disease control
Last updated Jun 26, 2026 19:13 UTC